Involvement of G proteins, cytoplasmic calcium, phospholipases, phospholipid-derived second messengers, and protein kinases in signal transduction from mitogenic cell surface receptors

  • Roy A. Frye
Part of the Cancer Treatment and Research book series (CTAR, volume 63)


The binding of growth factors to cell surface receptors rapidly induces a mitogenic signal transduction cascade, which results in transcriptional activation of early response genes such as fos [1,2]. This mitogenic signal transduction process involves a complex series of events, including tyrosine phosphorylation, Ras G-protein-dependent effects, activation of phospholipases, and activation of protein kinase C and other cytoplasmic serine/threonine protein kinases that transduce the mitogenic signal from the cell membrane to the cell nucleus. In addition to the rapid activation of fos transcription, there are rapid changes in phosphorylation of the Jun protein. The newly synthesized Fos protein complexes with newly phosphorylated Jun protein via leucine zipper motifs; this produces the active Fos:Jun heterodimer known as AP-1(Fos:Jun) [3,4]. AP-1(Fos:Jun) is a transcription control factor that modulates the transcription of numerous genes that contain AP-1 control elements. The activation of AP-1(Fos:Jun) in response to mitogenic stimuli occurs during the transition between the G0 phase (the resting stage of the cell cycle) and G1, phase (the stage when the cell becomes committed to undergo mitosis). This initiation of the G1 phase is followed several hours later by the activation of DNA synthesis (S phase) and eventually mitosis (M phase). This chapter focuses on the signal transduction pathways, which may connect stimulation of cell surface receptors to an important early G1 phase response, i.e., AP-1(Fos:Jun) formation via activation of fos transcription and Jun phosphorylation.


Tyrosine Kinase Tyrosine Phosphorylation Phorbol Ester Arachidonic Acid Release Mitogenic Stimulus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mehmet H, Rozengurt E: Regulation of c-fos expression in Swiss 3T3 cells: An interplay of multiple signal transduction pathways. Br Med Bull 47:76–86, 1991.PubMedGoogle Scholar
  2. 2.
    Rivera VM, Sheng M, Greenberg ME: The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes Dev 4:255–268, 1990.PubMedGoogle Scholar
  3. 3.
    Curran T, Franza BJ: Fos and Jun: The AP-1 connection. Cell 55:395–397, 1988.PubMedGoogle Scholar
  4. 4.
    Verma IM, Ransone LJ, Visvader J, Sassone CP, Lamph WW: fos-jun conspiracy: Implications for the cell. Ciba Found Symp 150:128–137, 1990.PubMedGoogle Scholar
  5. 5.
    Bourne HR, Sanders DA, McCormick F: The GTPase superfamily: A conserved switch for diverse cell functions. Nature 348:125–132, 1990.PubMedGoogle Scholar
  6. 6.
    Birnbaumer L: G proteins in signal transduction. Annu Rev Pharmacol Toxicol 30: 675–705, 1990.PubMedGoogle Scholar
  7. 7.
    Smrcka AV, Hepler JR, Brown KO, Sternweis PC: Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 251:804–807, 1991.PubMedGoogle Scholar
  8. 8.
    Taylor SJ, Chae HZ, Rhee SG, Exton JH: Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature 350:516–518, 1991.PubMedGoogle Scholar
  9. 9.
    Birnbaumer L, Abramowitz J, Yatani A, Okabe K, Mattera R, Graf R, Sanford J, Codina J, Brown AM: Roles of G proteins in coupling of receptors to ionic channels and other effector systems. Crit Rev Biochem Mol Biol 25:225–244, 1990.PubMedGoogle Scholar
  10. 10.
    Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature 341:197–205, 1989.PubMedGoogle Scholar
  11. 11.
    Kikkawa U, Kishimoto A, Nishizuka Y: The protein kinase C family: Heterogeneity and its implications. Annu Rev Biochem 58:31–44, 1989.PubMedGoogle Scholar
  12. 12.
    Nishizuka Y: The Albert Lasker Medical Awards. The family of protein kinase C for signal transduction. JAMA 262:1826–1833, 1989.PubMedGoogle Scholar
  13. 13.
    Moolenaar WH: G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation. Cell Growth Differ 2:359–364, 1991.PubMedGoogle Scholar
  14. 14.
    Jackson TR, Blair LA, Marshall J, Goedert M, Hanley MR: The mas oncogene encodes an angiotensin receptor. Nature 335:437–440, 1988.PubMedGoogle Scholar
  15. 15.
    Moser B, Schumacher C, von Tscharner V, Clark LI, Baggiolini M: Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem 266:10666–10671, 1991.PubMedGoogle Scholar
  16. 16.
    Thomas KM, Taylor L, Navarro J: The interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R. J Biol Chem 266:14839–14841, 1991.PubMedGoogle Scholar
  17. 17.
    Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F: Two G protein oncogenes in human endocrine tumors. Science 249:655–659, 1990.PubMedGoogle Scholar
  18. 18.
    Pace AM, Wong YH, Bourne HR: A mutant alpha subunit of Gi2 induces neoplastic transformation of Rat-1 cells. Proc Natl Acad Sci USA 88:7031–7035, 1991.PubMedGoogle Scholar
  19. 19.
    Lowndes JM, Gupta SK, Osawa S, Johnson GL: GTPase-deficient G alpha i2 oncogene gip2 inhibits adenylylcyclase and attenuates receptor-stimulated phospholipase A2 activity. J Biol Chem 266:14193–14197, 1991.PubMedGoogle Scholar
  20. 20.
    Kavanaugh WM, Williams LT, Ives HE, Coughlin SR: Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol Endocrinol 2:599–605, 1988.PubMedGoogle Scholar
  21. 21.
    Seuwen K, Magnaldo I, Pouyssegur J: Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature 335:254–256, 1988.PubMedGoogle Scholar
  22. 22.
    Millar JB, Rozengurt E: Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization. J Biol Chem 265:19973–19979, 1990.PubMedGoogle Scholar
  23. 23.
    Higashijima T, Burnier J, Ross EM: Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. Mechanism and structural determinants of activity. J Biol Chem 265:14176–14186, 1990.PubMedGoogle Scholar
  24. 24.
    Weingarten R, Ransnas L, Mueller H, Sklar LA, Bokoch GM: Mastoparan interacts with the carboxyl terminus of the alpha subunit of Gi. J Biol Chem 265:11044–11049, 1990.PubMedGoogle Scholar
  25. 25.
    Gil J, Higgins T, Rozengurt E: Mastoparan, a novel mitogen for Swiss 3T3 cells, stimulates pertussis toxin-sensitive arachidonic acid release without inositol phosphate accumulation. J Cell Biol 113:943–950, 1991.PubMedGoogle Scholar
  26. 26.
    Takuwa N, Iwamoto A, Kumada M, Yamashita K, Takuwa Y: Role of Ca2+ influx in bombesin-induced mitogenesis in Swiss 3T3 fibroblasts. J Biol Chem 266:1403–1409, 1991.PubMedGoogle Scholar
  27. 27.
    Takuwa N, Kumada M, Yamashita K, Takuwa Y: Mechanisms of bombesin-induced arachidonate mobilization in Swiss 3T3 fibroblasts. J Biol Chem 266:14237–14243, 1991.PubMedGoogle Scholar
  28. 28.
    Clark JD, Milona N, Knopf JL: Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci USA 87:7708–7712, 1990.PubMedGoogle Scholar
  29. 29.
    Kramer RM, Roberts EF, Manetta J, Putnam JE: The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem 266:5268–5272, 1991.PubMedGoogle Scholar
  30. 30.
    Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL: A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–1051, 1991.PubMedGoogle Scholar
  31. 31.
    Sharp JD, White DL, Chiou XG, Goodson T, Gamboa GC, McClure D, BÜrgett S, Hoskins J, Skatrud PL, Sportsman JR, Becker GW, Kang LH, Roberts EF, Kramer RM: Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem 266:14850–14853, 1991.PubMedGoogle Scholar
  32. 32.
    Channon JY, Leslie CC: A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J Biol Chem 265:5409–5413, 1990.PubMedGoogle Scholar
  33. 33.
    Leslie CC, Channon JY: Anionic phospholipids stimulate an arachidonoyl-hydrolyzing phospholipase A2 from macrophages and reduce the calcium requirement for activity. Biochim Biophys Acta 1045:261–270, 1990.PubMedGoogle Scholar
  34. 34.
    Lester DS, Collin C, Etcheberrigaray R, Alkon D: Arachidonic acid and diacylglycerol act synergistically to activate protein kinase C in vitro and in vivo. Biochem Biophys Res Commun 179:1522–1528, 1991.PubMedGoogle Scholar
  35. 35.
    Shinomura T, Asaoka Y, Oka M, Yoshida K, Nishizuka Y: Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: Its possible implications. Proc Natl Acad Sci USA 88:5149–5153, 1991.PubMedGoogle Scholar
  36. 36.
    Frye RA, Holz RW: Arachidonic acid release and catecholamine secretion from digitonin-treated chrorriaffin cells: Effects of micromolar calcium, phorbol ester, and protein alkylating agents. J Neurochem 44:265–273, 1985.PubMedGoogle Scholar
  37. 37.
    Halenda SP, Banga HS, Zavoico GB, Lau LF, Feinstein MB: Synergistic release of arachidonic acid from platelets by activators of protein kinase C and Ca2+ ionophores. Evidence for the role of protein phosphorylation in the activation of phospholipase A2 and independence from the Na+/H+ exchanger. Biochemistry 28:7356–7363, 1989.PubMedGoogle Scholar
  38. 38.
    Weiss BA, Insel PA: Intracellular Ca2+ and protein kinase C interact to regulate alpha 1-adrenergic-and bradykinin receptor-stimulated phospholipase A2 activation in Madin-Darby canine kidney cells. J Biol Chem 266:2126–2133, 1991.PubMedGoogle Scholar
  39. 39.
    Leslie CC: Kinetic properties of a high molecular mass arachidonoyl-hydrolyzing phospholipase A2 that exhibits lysophospholipase activity. J Biol Chem 266:11366–11371, 1991.PubMedGoogle Scholar
  40. 40.
    Brown AM, Birnbaumer L: Ionic channels and their regulation by G protein subunits. Annu Rev Physiol 52:197–213, 1990.PubMedGoogle Scholar
  41. 41.
    Exton JH: Signaling through phosphatidylcholine breakdown. J Biol Chem 265:1–4, 1990.PubMedGoogle Scholar
  42. 42.
    Martinson EA, Trilivas I, Brown JH: Rapid protein kinase C-dependent activation of phospholipase D leads to delayed 1,2-diglyceride accumulation. J Biol Chem 265:22282–22287, 1990.PubMedGoogle Scholar
  43. 43.
    Sandmann J, Wurtman RJ: Stimulation of phospholipase D activity in human neuroblastoma (LA-N-2) cells by activation of muscarinic acetylcholine receptors or by phorbol esters: Relationship to phosphoinositide turnover. J Neurochem 56:1312–1319, 1991.PubMedGoogle Scholar
  44. 44.
    Van der Meulen J, Haslam RJ: Phorbol ester treatment of intact rabbit platelets greatly enhances both the basal and guanosine 5’-[gamma-thio]triphosphate-stimulated phospholipase D activities of isolated platelet membranes. Physiological activation of phospholipase D may be secondary to activation of phospholipase C. Biochem J 271:693–700, 1990.Google Scholar
  45. 45.
    Van Blitterswijk WJ, Hilkmann H, de Widt J, van der Bend RL: Phospholipid metabolism in bradykinin-stimulated human fibroblasts. II. Phosphatidylcholine breakdown by phospholipases C and D; involvement of protein kinase C. J Biol Chem 266:10344–10350, 1991.PubMedGoogle Scholar
  46. 46.
    Pai JK, Pachter JA, Weinstein IB, Bishop WR: Overexpression of protein kinase C beta 1 enhances phospholipase D activity and diacylglycerol formation in phorbol ester-stimulated rat fibroblasts. Proc Natl Acad Sci USA 88:598–602, 1991.PubMedGoogle Scholar
  47. 47.
    Huckle WR, Prokop CA, Dy RC, Herman B, Earp S: Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner. Mol Cell Biol 10:6290–6298, 1990.PubMedGoogle Scholar
  48. 48.
    Golden A, Brugge JS: Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets. Proc Natl Acad Sci USA 86:901–905, 1989.PubMedGoogle Scholar
  49. 49.
    Rossomando AJ, Payne DM, Weber MJ, Sturgill TW: Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase. Proc Natl Acad Sci USA 86:6940–6943, 1989.PubMedGoogle Scholar
  50. 50.
    Zachary I, Gil J, Lehmann W, Sinnett SJ, Rozengurt E: Bombesin, vasopressin, and endothelin rapidly stimulate tyrosine phosphorylation in intact Swiss 3T3 cells. Proc Natl Acad Sci USA 88:4577–4581, 1991.PubMedGoogle Scholar
  51. 51.
    Seger R, Ahn NG, Boulton TG, Yancopoulos GD, Panayotatos N, Radziejewska E, Ericsson L, Bratlien RL, Cobb MH, Krebs EG: Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: Implications for their mechanism of activation. Proc Natl Acad Sci USA 88:6142–6146, 1991.PubMedGoogle Scholar
  52. 52.
    L’Allemain G, Pouyssegur J, Weber MJ: p42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways: Use of pertussis toxin as a discriminating factor. Cell Regul 2:675–684, 1991.Google Scholar
  53. 53.
    Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212, 1990.PubMedGoogle Scholar
  54. 54.
    Bazan JF: Haemopoietic receptors and helical cytokines. Immunol Today 11:350–354, 1990.PubMedGoogle Scholar
  55. 55.
    Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934–6938, 1990.PubMedGoogle Scholar
  56. 56.
    Bazan JF: Neuropoietic cytokines in the hematopoietic fold. Neuron 7:197–208, 1991.PubMedGoogle Scholar
  57. 57.
    Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ: A new cytokine receptor superfamily. Trends Biochem Sci 15:265–270, 1990.PubMedGoogle Scholar
  58. 58.
    Gearing DP, Thut CJ, VandenBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckman MP: Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp 130. EMBO J 10:2839–2848, 1991.PubMedGoogle Scholar
  59. 59.
    Nicola NA, Metcalf D: Subunit promiscuity among hematopoietic growth factor receptors. Cell 67:1–4, 1991.PubMedGoogle Scholar
  60. 60.
    Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendling F: A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 63:1137–1147, 1990.PubMedGoogle Scholar
  61. 61.
    Carter-Su C, Stubbart JR, Wang XY, Stred SE, Argetsinger LS, Shafer JA: Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase. J Biol Chem 264:18654–18661, 1989.PubMedGoogle Scholar
  62. 62.
    Fung MR, Scearce RM, Hoffman JA, Peffer NJ, Hammes SR, Hosking JB, Schmandt R, Kuziel WA, Haynes BF, Mills GB, Greene WC: A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptor. J Immunol 147:1253–1260, 1991.PubMedGoogle Scholar
  63. 63.
    Murata Y, Yamaguchi N, Hitoshi Y, Tominaga A, Takatsu K: Interleukin 5 and interleukin 3 induce serine and tyrosine phosphorylations of several cellular proteins in an interleukin 5-dependent cell line. Biochem Biophys Res Commun 173:1102–1108, 1990.PubMedGoogle Scholar
  64. 64.
    Kanakura Y, Druker B, Cannistra SA, Furukawa Y, Torimoto Y, Griffin JD: Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. Blood 76:706–715, 1990.PubMedGoogle Scholar
  65. 65.
    Isfort RJ, Ihle JN: Multiple hematopoietic growth factors signal through tyrosine phosphorylation. Growth Factors 2:213–220, 1990.PubMedGoogle Scholar
  66. 66.
    Quelle FW, Wojchowski DM: Proliferative action of erythropoietin is associated with rapid protein tyrosine phosphorylation in responsive B6SUt.EP cells. J Biol Chem 266:609–614, 1991.PubMedGoogle Scholar
  67. 67.
    Hatakeyama M, Kono T, Kobayashi N, Kawahara A, Levin SD, Perlmutter RM, Taniguchi T: Interaction of the IL-2 receptor with the sre-family kinase p561ck: Identification of novel intermolecular association. Science 252:1523–1528, 1991.PubMedGoogle Scholar
  68. 68.
    Horak ID, Gress RE, Lucas PJ, Horak EM, Waldmann TA, Bolen JB: T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p561ck. Proc Natl Acad Sci USA 88:1996–2000, 1991.PubMedGoogle Scholar
  69. 69.
    Fukunaga R, Ishizaka-Ikeda E, Pan C-X, Seto Y, Nagata S: Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J 10:2855–2865, 1991.PubMedGoogle Scholar
  70. 70.
    Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T: Critical cytoplasmic region of the interleukin 6 signal transducer gp 130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 88:11349–11353, 1991.PubMedGoogle Scholar
  71. 71.
    Moran MF, Koch CA, Anderson D, Ellis C, England L, Martin GS, Pawson T: Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci USA 87:8622–8626, 1990.PubMedGoogle Scholar
  72. 72.
    Hunter T: Cooperation between oncogenes. Cell 64:249–270, 1991.PubMedGoogle Scholar
  73. 73.
    Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S: Oncogenes and signal transduction. Cell 64:281–302, 1991.PubMedGoogle Scholar
  74. 74.
    Koch CA, Anderson D, Moran MF, Ellis C, Pawson T: SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252:668–674, 1991.PubMedGoogle Scholar
  75. 75.
    Margolis B, Li N, Koch A, Mohammadi M, Hurwitz DR, Zilberstein A, Ullrich A,Pawson T, Schlessinger J: The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma. Embo J 9:4375–4380, 1990.PubMedGoogle Scholar
  76. 76.
    Anderson D, Koch CA, Grey L, Ellis C, Moran MF, Pawson T: Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 250:979–982, 1990.PubMedGoogle Scholar
  77. 77.
    Hartmann T, Seuwen K, Roussel MF, Sherr CJ, Pouyssegur J: Functional expression of the human receptor for colony-stimulating factor 1 (CSF-1) in hamster fibroblasts: CSF-1 stimulates Na+/H+ exchange and DNA-synthesis in the absence of phosphoinositide breakdown. Growth Factors 2:289–300, 1990.PubMedGoogle Scholar
  78. 78.
    Margolis B, Zilberstein A, Franks C, Felder S, Kremer S, Ullrich A, Rhee SG, Skorecki K, Schlessinger J: Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis. Science 248:607–610, 1990.PubMedGoogle Scholar
  79. 79.
    Kaplan DR, Whitman M, Schaffhausen B, Pallas DC, White M, Cantley L, Roberts TM: Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 50:1021–1029, 1987.PubMedGoogle Scholar
  80. 80.
    Coughlin SR, Escobedo JA, Williams LT: Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science 243:1191–1194, 1989.PubMedGoogle Scholar
  81. 81.
    Yu JC, Heidaran MA, Pierce JH, Gutkind JS, Lombardi D, Ruggiero M, Aaronson SA: Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction. Mol Cell Biol 11:3780–3785, 1991.PubMedGoogle Scholar
  82. 82.
    Smith MR, DeGudicibus SJ, Stacey DW: Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540–543, 1986.PubMedGoogle Scholar
  83. 83.
    Aroian RV, Koga M, Mendel JE, Ohshima Y, Sternberg PW: The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily. Nature 348:693–699, 1990.PubMedGoogle Scholar
  84. 84.
    Simon MA, Bowtell DDL, Dodson GS, Laverty TR, Rubin GM: Rasl and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell 67:701–716, 1991.PubMedGoogle Scholar
  85. 85.
    Fortini ME, Simon MA, Rubin GM: Signalling by the sevenless protein tyrosine kinase is mimicked by Rasl activation. Nature 355:559–561, 1992.PubMedGoogle Scholar
  86. 86.
    Birchmeier C, Broek D, Wigler M: ras proteins can induce meiosis in Xenopus oocytes. Cell 43:615–621, 1985.PubMedGoogle Scholar
  87. 87.
    Korn LJ, Siebel CW, McCormick F, Roth RA: Ras p21 as a potential mediator of insulin action in Xenopus oocytes. Science 236:840–843, 1987.PubMedGoogle Scholar
  88. 88.
    Gautier J, Norbury C, Lohka M, Nurse P, Maller J: Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+. Cell 54:433–439, 1988.PubMedGoogle Scholar
  89. 89.
    Erikson E, Maller JL: Biochemical characterization of the p34cdc2 protein kinase component of purified maturation-promoting factor from Xenopus eggs. J Biol Chem 264:19577–19582, 1989.PubMedGoogle Scholar
  90. 90.
    Lacal JC: Diacylglycerol production in Xenopus laevis oocytes after microinjection of p21ras proteins is a consequence of activation of phosphatidylcholine metabolism. Mol Cell Biol 10:333–340, 1990.PubMedGoogle Scholar
  91. 91.
    Garcia de Herreros A, Dominguez I, Diaz-Meco MT, Graziani G, Cornett ME, Guddal PH, Johansen T, Moscat J: Requirement of phospholipase C-catalyzed hydrolysis of phosphatidylcholine for maturation of Xenopus laevis oocytes in response to insulin and ras p21. J Biol Chem 266:6825–6829, 1991.Google Scholar
  92. 92.
    Dominguez I, Marshall MS, Gibbs JB, Garcia de Herreros A, Cornet ME, Graziani G, Diaz-Meco MT, Johansen T, McCormick F, Moscat J: Role of GTPase activating protein in mitogenic signalling through phosphatidylcholine-hydrolysing phospholipase C. EMBO J. 10:3215–3220, 1991.PubMedGoogle Scholar
  93. 93.
    Clark MA, Shorr RG, Bomalaski JS: Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochem Biophys Res Commun 140:114–119, 1986.PubMedGoogle Scholar
  94. 94.
    Lopez-Barahona M, Kaplan PL. Cornet ME, Diaz-Meco MT, Larrodera P, Diaz-Laviada I, Municio AM, Moscat J: Kinetic evidence of a rapid activation of phosphatidylcholine hydrolysis by Ki-ras oncogene. Possible involvement in late steps of the mitogenic cascade. J Biol Chem 265:9022–9026, 1990.PubMedGoogle Scholar
  95. 95.
    Besterman JM, Duronio V, Cuatrecasas P: Rapid formation of diacylglycerol from phosphatidylcholine: A pathway for generation of a second messenger. Proc Natl Acad Sci USA 83:6785–6789, 1986.PubMedGoogle Scholar
  96. 96.
    Larrodera P, Cornet ME, Diaz-Meco MT, Lopez-Barahona M, Diaz-Laviada I, Guddal PH, Johansen T, Moscat J: Phospholipase C-mediated hydrolysis of phosphatidylcholine is an important step in PDGF-stimulated DNA synthesis. Cell 61:1113–1120, 1990.PubMedGoogle Scholar
  97. 97.
    Wright TM, Shin HS, Raben DM: Sustained increase in 1,2-diacylglycerol precedes DNA synthesis in epidermal-growth-factor-stimulated fibroblasts. Evidence for stimulated phosphatidylcholine hydrolysis. Biochem J 267:501–507, 1990.PubMedGoogle Scholar
  98. 98.
    Fisher GJ, Henderson PA, Voorhees JJ, Baidassare JJ: Epidermal growth factor-induced hydrolysis of phosphatidylcholine by phospholipase D and phospholipase C in human dermal fibroblasts. J Cell Physiol 146:309–317, 1991.PubMedGoogle Scholar
  99. 99.
    Imamura K, Dianoux A, Nakamura T, Kufe D: Colony-stimulating factor 1 activates protein kinase C in human monocytes. EMBO J 9:2423–2428, 1990.PubMedGoogle Scholar
  100. 100.
    Choudhury GG, Sylvia VL, Sakaguchi AY: Activation of a phosphatidylcholine-specific phospholipase C by colony stimulating factor 1 receptor requires tyrosine phosphorylation and a guanine nucleotide-binding protein. J Biol Chem 266:23147–23151, 1991.PubMedGoogle Scholar
  101. 101.
    Diaz LI, Larrodera P, Diaz MM, Cornet ME, Guddal PH, Johansen T, Moscat J: Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and sre oncogenes. EMBO J 9:3907–3912, 1990.Google Scholar
  102. 102.
    Ryves WJ, Evans AT, Olivier AR, Parket PJ, Evans FJ: Activation of the PKC-isotypes alpha, beta,, gamma, delta and epsilon by phorbol esters of different biological activités. FEBS Lett 288:5–9, 1991.PubMedGoogle Scholar
  103. 103.
    Kaibuchi K, Fukumoto Y, Oku N, Takai Y, Arai K, Muramatsu M: Molecular genetic analysis of the regulatory and catalytic domains of protein kinase C. J Biol Chem 264:13489–13496, 1989.PubMedGoogle Scholar
  104. 104.
    Ono Y, Fujii T, Igarashi K, Kuno T, Tanaka C, Kikkawa U, Nishizuka Y: Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc Natl Acad Sci USA 86:4868–4871, 1989.PubMedGoogle Scholar
  105. 105.
    Fisch TM, Prywes R, Roeder RG: c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore. Mol Cell Biol 7:3490–3502, 1987.PubMedGoogle Scholar
  106. 106.
    Boyle WJ, Smeal T, Defize LH, Angel P, Woodgett JR, Karin M, Hunter T: Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64:573–584, 1991.PubMedGoogle Scholar
  107. 107.
    Gilman MZ: The c-fos serum response element responds to protein kinase C-dependent and-independent signals but not to cyclic AMP. Genes Dev 2:394–402. 1988.PubMedGoogle Scholar
  108. 108.
    Gauthier RC, Fernandez A, Lamb NJ: ras-induced c-fos expression and proliferation in living rat fibroblasts involves C-kinase activation and the serum response element pathway. Embo J 9:171–180, 1990.Google Scholar
  109. 109.
    Morris JD, Price B, Lloyd AC, Self AJ, Marshall CJ, Hall A: Scrape-loading of Swiss 3T3 cells with ras protein rapidly activates protein kinase C in the absence of phosphoinositide hydrolysis. Oncogene 4:27–31, 1989.PubMedGoogle Scholar
  110. 110.
    Rodriguez PA, Rozengurt E: Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem Biophys Res Commun 120:1053–1059, 1984.Google Scholar
  111. 111.
    Stumpo DJ, Blackshear PJ: Insulin and growth factor effects on c-fos expression in normal and protein kinase C-deficient 3T3-L1 fibroblasts and adipocytes. Proc Natl Acad Sci USA 83:9453–9457, 1986.PubMedGoogle Scholar
  112. 112.
    Hoshi M, Nishida E, Sakai H: Characterization of a mitogen-activated, Ca2+-sensitive microtubule-associated protein-2 kinase. Eur J Biochem 184:477–486, 1989.PubMedGoogle Scholar
  113. 113.
    Anderson NG, Mailer JL, Tonks NK, Sturgill TW: Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343:651–653, 1990.PubMedGoogle Scholar
  114. 114.
    Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD: ERKs: A family of protein-serine/ threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663–675, 1991.PubMedGoogle Scholar
  115. 115.
    Ray LB, Sturgill TW: Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc Natl Acad Sci USA 84:1502–1506, 1987.PubMedGoogle Scholar
  116. 116.
    Hoshi M, Nishida E, Sakai H: Activation of a Ca2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts. J Biol Chem 263:5396–5401, 1988.PubMedGoogle Scholar
  117. 117.
    Boulton TG, Gregory JS, Cobb MH: Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubule-associated protein 2 kinase. Biochemistry 30:278–286, 1991.PubMedGoogle Scholar
  118. 118.
    Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR: Phosphorylation of c-jun mediated by MAP kinases. Nature 353:670–674, 1991.PubMedGoogle Scholar
  119. 119.
    Leevers SJ, Marshall CJ: Activation of extracellular signal-regulated kinase, ERK 2, by p21ras oncoprotein. EMBO J 11:569–574, 1992.PubMedGoogle Scholar
  120. 120.
    Sturgill TW, Ray LB, Erikson E, Mailer JL: Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715–718, 1988.PubMedGoogle Scholar
  121. 121.
    Chung J, Chen RH, Blenis J: Coordinate regulation of pp90rsk and a distinct protein-serine/threonine kinase activity that phosphorylates recombinant pp90rsk in vitro. Mol Cell Biol 11:1868–1874, 1991.PubMedGoogle Scholar
  122. 122.
    Chung J, Pelech SL, Blenis J: Mitogen-activated Swiss mouse 3T3 RSK kinases I and II are related to pp44mpk from sea star oocytes and participate in the regulation of pp90rsk activity. Proc Natl Acad Sci USA 88:4981–4985, 1991.PubMedGoogle Scholar
  123. 123.
    Chen RH, Chung J, Blenis J: Regulation of pp90rsk phosphorylation and S6 phosphotransferase activity in Swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction. Mol Cell Biol 11:1861–1867, 1991.PubMedGoogle Scholar
  124. 124.
    Anderson NG, Li P, Marsden LA, Williams N, Roberts TM, Sturgill TW: Raf-1 is a potential substrate for mitogen-activated protein kinase in vivo. Biochem J 277:573–576, 1991.PubMedGoogle Scholar
  125. 125.
    Lee R-M, Cobb MH, Blackshear PJ: Evidence that extracellular signal-regulated kinases are the insulin-activated Raf-1 kinase kinases. J Biol Chem 267:1088–1092, 1992.PubMedGoogle Scholar
  126. 126.
    Baichwal VR, Tjian R: Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: Differences between v-and c-Jun. Cell 63:815–825, 1990.PubMedGoogle Scholar
  127. 127.
    Baichwal VR, Park A, Tjian R: v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor. Nature 352:165–168, 1991.PubMedGoogle Scholar
  128. 128.
    Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354:494–496, 1991.PubMedGoogle Scholar
  129. 129.
    Rapp UR: Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 6:495–500, 1991.PubMedGoogle Scholar
  130. 130.
    Beck TW, Huleihel M, Gunnell M, Bonner TI, Rapp UR: The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus. Nucleic AcidsRes 15:595–609, 1987.Google Scholar
  131. 131.
    Kaibuchi K, Fukumoto Y, Oku N, Hori Y, Yamamoto T, Toyoshima K, Takai Y: Activation of the serum response element and 12-O-tetradecanoylphorbol-13-acetateresponse element by the activated c-raf-1 protein in a manner independent of protein kinase C. J Biol Chem 264:20855–20858, 1989.PubMedGoogle Scholar
  132. 132.
    Jamal S, Ziff E: Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals. Nature 344:463–466, 1990.PubMedGoogle Scholar
  133. 133.
    Heidecker G, Huleihel M, Cleveland JL, Kolch W, Beck TW, Lloyd P, Pawson T, Rapp UR: Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol 10:2503–2512, 1990.PubMedGoogle Scholar
  134. 134.
    Morrison DK, Kaplan DR, Rapp U, Roberts TM: Signal transduction from membrane to cytoplasm: Growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc Natl Acad Sci USA 85:8855–8859, 1988.PubMedGoogle Scholar
  135. 135.
    Carroll MP, Clark LI, Rapp UR, May WS: Interleukin-3 and granulocyte-macrophage colony-stimulating factor mediate rapid phosphorylation and activation of cytosolic c-raf. J Biol Chem 265:19812–19817, 1990.PubMedGoogle Scholar
  136. 136.
    Carroll MP, Spivak JL, McMahon M, Weich N, Rapp UR, May WS: Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem 266:14964–14969, 1991.PubMedGoogle Scholar
  137. 137.
    Baccarini M, Sabatini DM, App H, Rapp UR, Stanley ER: Colony stimulating factor-1 (CSF-1) stimulates temperature dependent phosphorylation and activation of the RAF-1 proto-oncogene product. EMBO J 9:3649–3657, 1990.PubMedGoogle Scholar
  138. 138.
    Lee RM, Rapp UR, Blackshear PJ: Evidence for one or more Raf-1 kinase kinase(s) activated by insulin and polypeptide growth factors. J Biol Chem 266:10351–10357, 1991.PubMedGoogle Scholar
  139. 139.
    Qureshi SA, Rim M, Bruder J, Kolch W, Rapp U, Sukhatme VP, Foster DA: An inhibitory mutant of c-Raf-1 blocks v-Src-induced activation of the Egr-1 promoter. J Biol Chem 266:20594–20597, 1991.PubMedGoogle Scholar
  140. 140.
    Kolch W, Heidecker G, Lloyd P, Rapp UR: Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349:426–428, 1991.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Roy A. Frye

There are no affiliations available

Personalised recommendations